All articles tagged with #covid 19 vaccines
The FDA reviewed 96 VAERS reports of child deaths through Aug. 14, 2025 and found no cases definitively linked to Covid vaccines; five were labeled possible and two probable, but causality could not be ruled out and VAERS limitations apply. The analysis, prompted by ongoing vaccine safety discussions, notes that most cases involved myocarditis and that infections can also trigger this condition.
Admiral Brian Christine, a surgeon who specialized in penile implants and has a history of far-right commentary, led a hantavirus press briefing in Nebraska during the Trump administration. CNN’s review uncovered past podcasts and posts in which he criticized vaccine mandates, promoted conspiracy theories about COVID-19, and questioned election legitimacy, raising questions about his qualifications for a senior public-health role despite limited infectious-disease experience. The piece also notes his background in private practice and a YouTube show on erectile dysfunction, underscoring concerns about appointing a non-traditional public health official to manage a health emergency.
An Op-Ed argues that the reconstituted ACIP is relitigating COVID vaccine safety using an unvalidated PACVS framework, proposing unvalidated diagnostics and dubious prevalence, while ignoring robust VSD surveillance showing no excess mortality post-vaccination; internal dissent among work-group members and a court ruling suggesting the process violated the Administrative Procedure Act highlight concerns that policy is being guided by conclusions rather than evidence. The piece warns that replacing GRADE with a weaker evidentiary standard would undermine vaccine policy across all vaccines, and notes the March meeting was postponed, set against a public health backdrop of measles outbreaks.
The WHO's TAG-CO-VAC recommends updating COVID-19 vaccine antigens to monovalent LP.8.1 to better target circulating SARS-CoV-2 variants, while noting that existing JN.1 lineage vaccines remain suitable. Ongoing surveillance and data collection are emphasized to adapt vaccine strategies as the virus evolves.
FDA Commissioner Martin Makary emphasized the need for greater humility and transparency from the government to rebuild public trust in health advice, criticizing recent communication issues and advocating for flexible, science-based decision-making.
A group of former FDA leaders criticized the agency's new vaccine safety policies, arguing that they undermine scientific evidence and could harm public health, especially regarding COVID-19 and flu vaccines, amid ongoing political influences on vaccine policy.
An FDA official proposed new, vague standards for vaccine testing that could hinder the development and access to vaccines, including demanding randomized controlled trials for vaccines like those for COVID-19 and influenza, which experts argue are impractical and could delay or restrict vaccine availability, especially for vulnerable populations like pregnant women and children.
The FDA's top vaccine official mentioned a review linking 10 children's deaths to COVID-19 vaccines, prompting calls for more transparency and scrutiny from health experts, who criticize the lack of published data and warn against politicizing vaccine safety.
A CDC vaccine panel presentation raised safety concerns about mRNA COVID-19 vaccines, but experts say these are based on misinterpretations or flawed science, and the vaccines are extensively tested and safe for the public.
Research shows that COVID-19 mRNA vaccines can enhance the effectiveness of cancer immunotherapy by 'warming up' cold tumors, significantly improving survival rates in lung and skin cancer patients, potentially leading to a new approach in cancer treatment.
A study finds that COVID-19 mRNA vaccines, like Pfizer and Moderna, can boost the immune system to recognize and kill cancer cells, especially when combined with immunotherapy, potentially extending benefits to more cancer patients. The vaccines act as an immune alarm, helping to turn 'cold' tumors 'hot,' and are being tested in clinical trials for lung cancer.
A study by the University of Texas MD Anderson and the University of Florida found that mRNA COVID-19 vaccines not only protect against the virus but also nearly double the median survival time of cancer patients by boosting the immune system.
COVID-19 mRNA vaccines enhance the effectiveness of immune checkpoint inhibitors in cancer treatment by stimulating innate and adaptive immune responses, increasing tumor PD-L1 expression, and potentially restoring immune sensitivity in 'cold' tumors, leading to improved survival outcomes in patients with NSCLC and melanoma.
Preliminary research suggests that Pfizer and Moderna mRNA COVID-19 vaccines may enhance immune responses in some cancer patients undergoing immunotherapy, potentially improving survival rates, especially in lung and skin cancers, by acting as immune system stimulants beyond their role in fighting COVID-19.
A study presented at the 2025 European Society for Medical Oncology Congress suggests that COVID-19 mRNA vaccines may enhance survival in patients with advanced lung and melanoma cancers by sensitizing tumors to immunotherapy, nearly doubling median survival times when administered within 100 days of starting immune checkpoint inhibitors.